Procoralan was expanded in the health insurance benefit while Entresto created a new paradigm by FDA approval

- ‘Procoralan(generic name: ivabradine)’ meets a new era by expansion of the health insurance benefit

Procoralan(Servier Korea, generic name: ivabradine) was first approved as a ‘chronic stable angina’ treatment in 2009, acquired approval for its effectiveness in ‘chronic cardiac insufficiency’ from the Ministry of Food and Drug Safety on May 2014 and has received the National Health Insurance...